Filing Details
- Accession Number:
- 0001883850-22-000086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-02 16:04:51
- Reporting Period:
- 2022-10-31
- Accepted Time:
- 2022-11-02 16:04:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-10-31 | 2,000 | $381.92 | 30,744 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-10-31 | 1,518 | $751.24 | 29,226 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2022-11-01 | 1 | $750.00 | 29,225 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 40 | $753.23 | 29,185 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 80 | $754.39 | 29,105 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 81 | $755.46 | 29,024 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 42 | $758.20 | 28,982 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 70 | $759.39 | 28,912 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 13 | $760.90 | 28,899 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 119 | $761.36 | 28,780 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 17 | $762.92 | 28,763 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-01 | 19 | $763.10 | 28,744 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-10-31 | 2,000 | $0.00 | 2,000 | $381.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,300 | 2026-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 250 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 80 shares of Company stock on November 1, 2022 at prices ranging from $754.20 to $754.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
- Represents volume-weighted average price of sales of 81 shares of Company stock on November 1, 2022 at prices ranging from $755.03 to $755.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
- Represents volume-weighted average price of sales of 42 shares of Company stock on November 1, 2022 at prices ranging from $758.15 to $758.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
- Represents volume-weighted average price of sales of 70 shares of Company stock on November 1, 2022 at prices ranging from $759.23 to $759.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
- Represents volume-weighted average price of sales of 13 shares of Company stock on November 1, 2022 at prices ranging from $760.81 to $760.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
- Represents volume-weighted average price of sales of 119 shares of Company stock on November 1, 2022 at prices ranging from $761.19 to $761.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
